OAKLAND, CA, November
16, 1999
DoubleTwist, Inc.
(previously called Pangea Systems®) and AlphaGene, Inc. today announced an
e-commerce partnership making 50,000 potentially novel genes available to
every life scientist. The collaboration provides researchers with access
to AlphaGene's proprietary cDNA sequence data through DoubleTwist.com,
DoubleTwist's Internet portal for on-line genetic research. A DoubleTwist user
researching a partial-length DNA sequence will automatically receive
notification when a corresponding full-length cDNA exists in AlphaGene's
database. AlphaGene will give the DoubleTwist user an opportunity to
license or purchase the clone.
As a result of the AlphaGene
partnership, DoubleTwist users will save time and money with the ability
to immediately access and license full-length clones from AlphaGene's
extensive libraries. DoubleTwist users will also gain the potential to
discover novel genes from known EST's (expressed sequence tags) through
access to AlphaGene's proprietary database.
"DoubleTwist users will
greatly benefit from the ability to easily access AlphaGene's significant
sequence data, including over 50,000 potentially novel genes," said
John Couch, chief executive officer of DoubleTwist, Inc.. "Through
relationships like this one, DoubleTwist is continuing to enable life
scientists to simplify and accelerate on-line genetic research."
Ideal
gene inventory display
"We are excited about
this new channel for distributing our proprietary sequence data directly
to researchers worldwide," said Donald McCarren, Ph.D., chief
executive officer of AlphaGene. "We think DoubleTwist is an ideal
mechanism for displaying AlphaGene's large gene inventory to the life
science research community."
DoubleTwist is a leading-edge
web portal integrating powerful and sophisticated research tools and data
through an easy-to-use interface accessible to any life scientist
interested in genetic research. The site uses automated search agents to
seek out and interpret data based on the user's scientific questions,
increasing the efficiency of conducting research and accelerating the gene
discovery process. DoubleTwist is currently being validated at Stanford
University and is scheduled for general commercial launch by January 2000.
DoubleTwist, Inc. is a leading provider of software and
technologies for advanced bioinformatics -- the application of information
technology to life science research and development. DoubleTwist's
bioinformatics software and technologies simplify and accelerate the
discovery process through powerful computational and data management
processes. Incorporated in 1993, DoubleTwist is a privately held,
Oakland, California-based company.
For more information, contact
DoubleTwist at (510) 628-0100, or e-mail us at info-pr@doubletwist.com
or visit http://www.doubletwist.com.
AlphaGene, Inc. is a
functional genomics company developing novel technologies for gene
discovery to accelerate drug development for major human diseases.
Building upon its patented core technologies, AlphaGene has developed an
integrated platform that includes gene arraying on biochips for
identifying differentially expressed genes in disease or other cell
states. AlphaGene also employs specialized assays and sophisticated
bioinformatics to aid in the identification of critical disease-specific
targets. The company is located in Woburn, Massachusetts.
For more information, contact
AlphaGene, Inc. at (781) 933-4446 or email us at info@alphagene.com..
Copyright©
1999, DoubleTwist, Inc. All rights reserved. Pangea Systems and
DoubleTwist.com are registered trademarks of DoubleTwist,
Inc. The
Pangea Systems, Doubletwist logo and the DoubleTwist.com logo are
trademarks of DoubleTwist, Inc. All other trademarks, brands and names
are property of their respective owners.
